Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
Workplace Wellness Programs Do Not Impact Clinical Outcomes
However, improvements seen in employees' health beliefs, number having a primary care physician
Delay in Treatment Seen for Acute Ischemic Stroke During COVID-19
Mean interval from last-known-well time to presentation significantly longer in March 2020
COVID-19 Drug Studies Questioned
Journals issue 'expressions of concern' over two recent studies of medications and their effect on COVID-19 patients
Women’s Acute Coronary Symptoms No Longer ‘Atypical’
Chest pain remains the most common presentation by both men and women
Reducing Number of BP Meds May Be Safe in Some Older Adults
No significant change in systolic BP control seen at 12 weeks versus pretrial medication
Weight, Blood Pressure Higher in Younger Patients With T2DM
Differentials for weight, BP for those with, without T2DM greater for younger versus older patients
Chest CT Often Normal in Pediatric COVID-19 Patients
No change was seen in 10 of the 11 follow-up CT examinations carried out
Young With Intellectual Disability More Likely to Die of COVID-19
Concentration of COVID-19 cases, case fatality in those with IDD higher at younger ages
One-Third of Lupus Patients Have Trouble Refilling Hydroxychloroquine
Patients report lack of availability at usual pharmacy, waiting weeks for refills, only getting partial refills
